Peab Toekomstige groei
Future criteriumcontroles 2/6
Peab zal naar verwachting groeien in winst en omzet met respectievelijk 10.6% en 3.4% per jaar. De winst per aandeel zal naar verwachting groeien met 10.6% per jaar. Het rendement op het eigen vermogen zal over 3 jaar naar verwachting 12.5% zijn.
Belangrijke informatie
10.6%
Groei van de winst
10.6%
Groei van de winst per aandeel
Construction winstgroei | 19.8% |
Inkomstengroei | 3.4% |
Toekomstig rendement op eigen vermogen | 12.5% |
Dekking van analisten | Low |
Laatst bijgewerkt | 28 Oct 2024 |
Recente toekomstige groei-updates
Recent updates
We Think Peab (STO:PEAB B) Is Taking Some Risk With Its Debt
Nov 02Peab AB (publ)'s (STO:PEAB B) Shares Lagging The Market But So Is The Business
Sep 25Peab AB (publ)'s (STO:PEAB B) Intrinsic Value Is Potentially 24% Below Its Share Price
Sep 04Is Now The Time To Look At Buying Peab AB (publ) (STO:PEAB B)?
Aug 13Peab's (STO:PEAB B) Conservative Accounting Might Explain Soft Earnings
Jul 24These 4 Measures Indicate That Peab (STO:PEAB B) Is Using Debt Extensively
Jun 12Earnings Update: Peab AB (publ) (STO:PEAB B) Just Reported Its First-Quarter Results And Analysts Are Updating Their Forecasts
May 09It Looks Like Peab AB (publ)'s (STO:PEAB B) CEO May Expect Their Salary To Be Put Under The Microscope
Apr 30Peab's (STO:PEAB B) Dividend Will Be Reduced To SEK1.50
Apr 25Peab (STO:PEAB B) Has Announced That Its Dividend Will Be Reduced To SEK1.50
Apr 05What Does Peab AB (publ)'s (STO:PEAB B) Share Price Indicate?
Mar 11Peab (STO:PEAB B) Is Paying Out Less In Dividends Than Last Year
Feb 22Peab AB (publ) (STO:PEAB B) Surges 28% Yet Its Low P/E Is No Reason For Excitement
Feb 18Does This Valuation Of Peab AB (publ) (STO:PEAB B) Imply Investors Are Overpaying?
Dec 08At kr49.02, Is Peab AB (publ) (STO:PEAB B) Worth Looking At Closely?
Nov 18These 4 Measures Indicate That Peab (STO:PEAB B) Is Using Debt Extensively
Nov 02A Look At The Intrinsic Value Of Peab AB (publ) (STO:PEAB B)
Aug 18What Is Peab AB (publ)'s (STO:PEAB B) Share Price Doing?
Jul 18Peab (STO:PEAB B) Use Of Debt Could Be Considered Risky
Jul 04Calculating The Fair Value Of Peab AB (publ) (STO:PEAB B)
Apr 28What Does Peab AB (publ)'s (STO:PEAB B) Share Price Indicate?
Apr 13Peab (STO:PEAB B) Has A Somewhat Strained Balance Sheet
Feb 25Calculating The Intrinsic Value Of Peab AB (publ) (STO:PEAB B)
Jan 15Is Peab AB (publ) (STO:PEAB B) Potentially Undervalued?
Dec 16Is It Too Late To Consider Buying Peab AB (publ) (STO:PEAB B)?
Sep 06Does Peab (STO:PEAB B) Have A Healthy Balance Sheet?
Aug 07Is Peab AB (publ) (STO:PEAB B) Potentially Undervalued?
Jun 02Is Peab (STO:PEAB B) Using Too Much Debt?
Apr 20Peab's (STO:PEAB B) Shareholders Will Receive A Bigger Dividend Than Last Year
Apr 05Peab (STO:PEAB B) Will Pay A Larger Dividend Than Last Year At kr5.00
Feb 07Winst- en omzetgroeiprognoses
Datum | Inkomsten | Inkomsten | Vrije kasstroom | Geldmiddelen uit operationele activiteiten | Gem. Aantal analisten |
---|---|---|---|---|---|
12/31/2026 | 65,493 | 2,071 | -420 | 1,687 | 3 |
12/31/2025 | 60,818 | 1,718 | 808 | 2,424 | 4 |
12/31/2024 | 58,299 | 1,658 | 3,654 | 3,578 | 3 |
9/30/2024 | 61,463 | 1,482 | 5,899 | 6,750 | N/A |
6/30/2024 | 60,902 | 1,373 | 5,485 | 6,579 | N/A |
3/31/2024 | 60,072 | 1,966 | 1,918 | 3,213 | N/A |
12/31/2023 | 61,600 | 1,988 | 2,596 | 3,916 | N/A |
9/30/2023 | 61,376 | 2,336 | -718 | 742 | N/A |
6/30/2023 | 62,414 | 2,424 | -1,203 | 365 | N/A |
3/31/2023 | 62,774 | 1,825 | -2,284 | -744 | N/A |
12/31/2022 | 61,933 | 1,832 | -3,003 | -1,556 | N/A |
9/30/2022 | 62,296 | 2,394 | -267 | -322 | N/A |
6/30/2022 | 61,587 | 2,463 | -498 | 686 | N/A |
3/31/2022 | 59,936 | 2,448 | 1,108 | 2,177 | N/A |
12/31/2021 | 58,923 | 2,377 | 1,737 | 2,818 | N/A |
9/30/2021 | 57,408 | 2,986 | 1,015 | 3,333 | N/A |
6/30/2021 | 58,124 | 3,046 | 3,437 | 4,409 | N/A |
3/31/2021 | 59,106 | 3,014 | 5,127 | 6,069 | N/A |
12/31/2020 | 59,852 | 3,182 | 6,751 | 7,693 | N/A |
9/30/2020 | 59,318 | 2,105 | 5,556 | 6,633 | N/A |
6/30/2020 | 55,983 | 1,804 | 2,046 | 3,136 | N/A |
3/31/2020 | 55,334 | 2,087 | 962 | 2,276 | N/A |
12/31/2019 | 56,303 | 2,656 | 2,559 | 4,013 | N/A |
9/30/2019 | 55,693 | 2,709 | 2,262 | 3,616 | N/A |
6/30/2019 | 55,269 | 2,774 | 2,073 | 3,649 | N/A |
3/31/2019 | 53,582 | 2,520 | 1,649 | 3,214 | N/A |
12/31/2018 | 52,233 | 2,100 | -1,635 | -250 | N/A |
9/30/2018 | 51,878 | 2,074 | -1,064 | 288 | N/A |
6/30/2018 | 51,028 | 2,055 | N/A | 1,419 | N/A |
3/31/2018 | 50,366 | 2,008 | N/A | 1,022 | N/A |
12/31/2017 | 49,981 | 2,067 | N/A | 2,839 | N/A |
9/30/2017 | 49,370 | 1,948 | N/A | 3,771 | N/A |
6/30/2017 | 49,131 | 1,892 | N/A | 3,096 | N/A |
3/31/2017 | 48,911 | 1,881 | N/A | 4,164 | N/A |
12/31/2016 | 46,337 | 1,727 | N/A | 3,455 | N/A |
9/30/2016 | 44,682 | 1,030 | N/A | 2,651 | N/A |
6/30/2016 | 45,034 | 950 | N/A | 3,793 | N/A |
3/31/2016 | 44,031 | 833 | N/A | 3,171 | N/A |
12/31/2015 | 44,376 | 798 | N/A | 2,825 | N/A |
9/30/2015 | 44,365 | 1,100 | N/A | 3,138 | N/A |
6/30/2015 | 43,468 | 1,123 | N/A | 3,121 | N/A |
3/31/2015 | 43,504 | 1,060 | N/A | 4,061 | N/A |
12/31/2014 | 43,630 | 1,027 | N/A | 3,750 | N/A |
9/30/2014 | 44,343 | 1,231 | N/A | 2,675 | N/A |
6/30/2014 | 44,054 | 1,098 | N/A | 1,051 | N/A |
3/31/2014 | 42,820 | 287 | N/A | 364 | N/A |
12/31/2013 | 43,127 | 298 | N/A | -174 | N/A |
Toekomstige groeivoorspellingen analisten
Verdiensten versus spaarpercentage: De verwachte winstgroei PEAB B ( 10.6% per jaar) ligt boven de spaarquote ( 1.1% ).
Winst versus markt: De winst van PEAB B ( 10.6% per jaar) zal naar verwachting langzamer groeien dan de markt Swedish ( 15.7% per jaar).
Hoge groeiwinsten: De winst van PEAB B zal naar verwachting groeien, maar niet aanzienlijk.
Omzet versus markt: De omzet van PEAB B ( 3.4% per jaar) zal naar verwachting sneller groeien dan de markt Swedish ( 0.02% per jaar).
Hoge groei-inkomsten: De omzet van PEAB B ( 3.4% per jaar) zal naar verwachting langzamer groeien dan 20% per jaar.
Groeiprognoses winst per aandeel
Toekomstig rendement op eigen vermogen
Toekomstige ROE: Het rendement op eigen vermogen PEAB B zal naar verwachting over 3 jaar laag zijn ( 12.5 %).